Condition
Hodgkin's Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Hodgkin's Lymphoma clinical trials that are recruiting, at sites in 2 countries (most in United States (3), China (2)). By phase: Phase 1 (2), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Hodgkin's Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment for relapsed Hodgkin's and Anaplastic Large Cell Lymphoma using LCAR-HL30 | Phase 1 | Shanghai | Recruiting | Jul 10, 2024 |
| Combining Azacitidine and Pembrolizumab for Hodgkin's Lymphoma | Phase 2 | Houston, Texas | Recruiting | May 2, 2022 |
| Using modified T cells to treat relapsed lymphoma | Phase 1 | Houston, Texas and 1 other locations | Recruiting | Sep 28, 2016 |
| CD30-targeted CAR T-cell therapy for relapsed and refractory lymphomas | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Oct 8, 2014 |
| Study on how cancer treatment affects women's sexual and reproductive health | — | Basking Ridge, New Jersey and 6 other locations | Recruiting | Feb 11, 2013 |
All recruiting trials (5)
-
Treatment for relapsed Hodgkin's and Anaplastic Large Cell Lymphoma using LCAR-HL30
This study is testing a new treatment called LCAR-HL30 to see if it can help adults with relapsed Hodgkin's Lymphoma and Anaplastic Large Cell Lymphoma feel better.
-
Combining Azacitidine and Pembrolizumab for Hodgkin's Lymphoma
This study is testing if combining two medications, azacitidine and pembrolizumab, can help children and adults with relapsed or hard-to-treat Hodgkin's lymphoma feel better and live longer.
-
Using modified T cells to treat relapsed lymphoma
This study is testing if specially modified T cells can help people with relapsed Hodgkin's and Non-Hodgkin lymphoma fight their cancer more effectively after chemotherapy.
-
CD30-targeted CAR T-cell therapy for relapsed and refractory lymphomas
This study is testing a new treatment using modified T cells to see if it can help people with relapsed or hard-to-treat Hodgkin's and Non-Hodgkin's lymphoma.
-
Study on how cancer treatment affects women's sexual and reproductive health
This study looks at how cancer treatments affect the sexual and reproductive health of premenopausal women with early-stage breast cancer or aggressive lymphoma.
Related topics
Quick answers
How many Hodgkin's Lymphoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.